AbCellera Biologics (ABCL) Shares Outstanding (Entity) (2020 - 2026)

AbCellera Biologics (ABCL) Shares Outstanding (Entity) (2020 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Entity.) (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 253.35 Mn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 139.80 Mn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 62.54 Mn
4 Revolution Medicines 43.64 Bn 43.64 Bn - 214.24 Mn
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 113.02 Mn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn -
7 Royalty Pharma 33.72 Bn 35.84 Bn - 575.47 Mn
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 133.73 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 218.28 Mn
10 AbCellera Biologics 3.49 Bn 3.49 Bn - 306.47 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 306.47 Mn
Mar 31, 2026 303.95 Mn
Dec 31, 2025 300.60 Mn
Sep 30, 2025 299.01 Mn
Jun 30, 2025 298.65 Mn
Mar 31, 2025 298.36 Mn
Dec 31, 2024 295.76 Mn
Sep 30, 2024 295.16 Mn
Jun 30, 2024 294.67 Mn
Mar 31, 2024 293.62 Mn
Dec 31, 2023 290.82 Mn
Sep 30, 2023 289.78 Mn
Jun 30, 2023 289.19 Mn
Mar 31, 2023 288.43 Mn
Dec 31, 2022 286.85 Mn
Sep 30, 2022 285.76 Mn
Jun 30, 2022 285.05 Mn
Mar 31, 2022 284.52 Mn
Dec 31, 2021 283.26 Mn
Sep 30, 2021 281.15 Mn